AI314976 activators encompass a diverse array of chemical compounds that, through various cellular mechanisms, enhance the functional activity of the protein AI314976. Compounds such as Forskolin and Rolipram raise intracellular cAMP levels, which can indirectly up-regulate AI314976 activity by activating PKA-dependent signaling pathways; these pathways are capable of phosphorylating AI314976 or proteins linked to its regulation, thereby increasing AI314976's functional role. Similarly, Sildenafil and Zaprinast inhibit PDE5, resulting in elevated levels of cGMP, and along with the beta-adrenergic agonist Isoproterenol, they activate kinase pathways such as PKA and PKG, potentially leading to the phosphorylation of regulatory proteins that enhance AI314976 activity. The utilization of ionophores like Ionomycin and A23187, which increase intracellular calcium, also serves to activate calcium-dependent kinases and signaling pathways that may indirectly heighten the activity of AI314976.
In contrast, compounds such as PMA work through the activation of PKC, a different kinase capable of phosphorylating proteins within theAI314976 signaling network. The PI3K pathway, known for its role in a plethora of cellular functions, can be modulated by the inhibitor LY294002, which may indirectly enhance AI314976 activity by affecting downstream proteins that interact with or regulate AI314976. The targeted action of SB203580, which inhibits p38 MAPK, and the effect of Okadaic Acid on protein phosphatases PP1 and PP2A, both contribute to shifting the phosphorylation state of proteins within the signaling landscape, potentially favoring AI314976 activation. Furthermore, KN-93's selective inhibition of CaMKII may result in an indirect enhancement of AI314976's activity by influencing the phosphorylation balance within the associated pathways. Collectively, these activators employ distinct yet converging biochemical pathways to amplify the functional activity of AI314976, demonstrating the complexity of cellular signaling and the nuanced regulation of protein activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that elevates intracellular calcium levels, activating calcium/calmodulin-dependent protein kinases (CaMK) which could enhance AI314976 activity by modifying proteins in the AI314976 signaling cascade. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram inhibits PDE4, leading to an increase in intracellular cAMP levels, which may boost AI314976 activity via the PKA signaling pathway by phosphorylating AI314976 or proteins that interact with AI314976. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can enhance the activity of AI314976 by phosphorylation of AI314976 or associated proteins within the AI314976 signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can alter the PI3K/Akt pathway, resulting in changes to downstream signaling which may lead to the enhancement of AI314976 activity through indirect effects on AI314976 regulation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium, activating calcium-dependent signaling pathways and protein kinases that could enhance AI314976 signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can shift cellular signaling dynamics, possibly enhancing AI314976 activity by altering the phosphorylation state of proteins in pathways where AI314976 is involved. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is an inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation of proteins within signaling pathways that may include AI314976, hence potentially enhancing AI314976 activity. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDE5 and PDE6, which increases cGMP levels in cells, potentially enhancing AI314976 activity by activating the cGMP-dependent protein kinase (PKG) pathway, affecting AI314976-related signaling. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of CaMKII, which paradoxically may enhance AI314976 activity by altering the balance of signaling through pathways that modulate or interact with AI314976. | ||||||